People living with HIV who inject or have injected non-prescription drugs: Evidence of substantial differences in health inequalities and experiences of clinical care.
HIV
injections
intravenous
recreational drug use
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
25
04
2023
received:
14
09
2022
accepted:
27
04
2023
medline:
4
9
2023
pubmed:
12
5
2023
entrez:
12
5
2023
Statut:
ppublish
Résumé
This study investigates differences in health and well-being associated with current, past or no injecting drug use (IDU) among people living with HIV (PLHIV) in Australia, identifying key health care considerations between injecting experiences. Data were extracted from the HIV Futures 9 study; a survey of PLHIV conducted in 2018-2019. Chi-square and analysis of variance analyses compared clinical and treatment characteristics, major physical and mental comorbidities, sexually transmitted infection diagnoses, and quality of life for those who reported current (last 12 months), past (12+ months ago) or no IDU. Current IDU (n = 106) was associated with higher rates of sexually transmitted infection testing and diagnoses, higher frequency of self-reported antiretroviral therapy non-adherence due to drug use and greater social quality of life than past (n = 126) or no IDU (n = 508; total N = 740). Past and current IDUs were associated with more mental illness diagnoses and self-reported concern about drug use. Past IDU was associated with more physical comorbidities, lower satisfaction with clinical care and greater difficulty in affording health care than current or no IDU. Past and current IDUs are associated with unique health concerns. However, past IDU appears to be related to greater dissatisfaction in navigating health care than individuals with current IDU experience. Higher social connection and the types of services being accessed by individuals who currently inject may play a role in shaping service satisfaction. Peer-based interventions to help support individuals in accessing services that are affirming of their needs is an ongoing priority.
Substances chimiques
Nonprescription Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1517-1528Informations de copyright
© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
Références
Beyrer C, Abdool KQ. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS. 2013;8:306-10.
Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5:e1192-e207.
Bourne A, Weatherburn P. Substance use among men who have sex with men: patterns, motivations, impacts and intervention development need. Sex Transm Infect. 2017;93:342-6.
Lea T, Mao L, Hopwood M, Prestage G, Zablotska I, de Wit J, et al. Methamphetamine use among gay and bisexual men in Australia: Trends in recent and regular use from the Gay Community Periodic Surveys. Int J Drug Policy. 2016;29:66-72.
Schmidt AJ, Bourne A, Weatherburn P, Reid D, Marcus U, Hickson F. Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS). Int J Drug Policy. 2016;38:4-12.
Wei C, Guadamuz TE, Lim SH, Huang Y, Koe S. Patterns and levels of illicit drug use among men who have sex with men in Asia. Drug Alcohol Depend. 2012;120:246-9.
Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129:674-97.
Bryant J, Hopwood M, Dowsett GW, Aggleton P, Holt M, Lea T, et al. The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. Int J Drug Policy. 2018;55:242-8.
Drysdale K, Bryant J, Dowsett GW, Lea T, Treloar C, Aggleton P, et al. Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex. Int J Drug Policy. 2021;93:103163.
Power J, Mikołajczak G, Bourne A, Brown G, Leonard W, Lyons A, et al. Sex, drugs and social connectedness: wellbeing among HIV-positive gay and bisexual men who use party-and-play drugs. Sex Health. 2018;15:135-43.
Race K, Lea T, Murphy D, Pienaar K. The future of drugs: recreational drug use and sexual health among gay and other men who have sex with men. Sex Health. 2017;14:42-50.
Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2021. Sydney, Australia: Kirby Institute, UNSW Sydney; 2021.
Hammoud MA, Jin F, Maher L, Bourne A, Haire B, Saxton P, et al. Biomedical HIV protection among gay and bisexual men who use crystal methamphetamine. AIDS Behav. 2020;24:1400-13.
Hammoud MA, Vaccher S, Jin F, Bourne A, Maher L, Holt M, et al. HIV Pre-exposure Prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the nonuse of PrEP among eligible men: Results from a prospective cohort study. J Acquir Immune Defic Syndr. 2019;81:e73-84.
Kolstee J, Holt M, Jin J, Hammoud MA, Degenhardt L, Maher L, et al. Characteristics of gay and bisexual men who rarely use HIV risk reduction strategies during condomless anal intercourse: Results from the FLUX national online cohort study. PLoS One. 2020;15:e0233922.
Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, et al. Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study. Lancet HIV. 2014;1:e22-31.
Noroozi M, Higgs P, Noroozi A, Armoon B, Mousavi B, Alikhani R, et al. Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching. Harm Reduct J. 2020;17:66.
Norman T, Bourne A, Power J, Meléndez-Torres GJ. Non-prescription drug use among HIV positive gay and bisexual men in Australia: a latent class analysis and comparison of health and well-being. Int J Drug Policy. 2022;100:103526.
Degenhardt L, Bharat C, Glantz MD, Sampson NA, Scott K, Lim CCW, et al. The epidemiology of drug use disorders cross-nationally: findings from the WHO's World Mental Health Surveys. Int J Drug Policy. 2019;71:103-12.
Prestage G, Hammoud M, Jin F, Degenhardt L, Bourne A, Maher L. Mental health, drug use and sexual risk behavior among gay and bisexual men. Int J Drug Policy. 2018;55:169-79.
Glei DA, Weinstein M. Drug and alcohol abuse: the role of economic insecurity. Am J Health Behav. 2019;43:838-53.
Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235-48.
He J, Wang Y, Du Z, Liao J, He N, Hao Y. Peer education for HIV prevention among high-risk groups: a systematic review and meta-analysis. BMC Infect Dis. 2020;20:338.
Schroeder SE, Bourne A, Doyle J, Stoove M, Hellard M, Pedrana A. “It's not just the hit itself”: the social practice of injecting drug use among gay and bisexual men in Australia. Int J Drug Policy. 2022;103:103642.
Freestone J, Siefried KJ, Prestage G, Hammoud M, Molyneux A, Bourne A. Individual level peer interventions for gay and bisexual men who have sex with men between 2000 and 2020: a scoping review. PLoS One. 2022;17:e0270649.
Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70:531-8.
Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17:53.
Kelly J, Amirkhanian Y, Yakovlev A, Musatov V, Meylakhs A, Kuznetsova A, et al. Stigma reduces and social support increases engagement in medical care among persons with HIV infection in St. Petersburg, Russia. J Int AIDS Soc. 2014;17(4 Suppl 3):19618.
Schuster MA, Collins R, Cunningham WE, Morton SC, Zierler S, Wong M, et al. Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care. J Gen Intern Med. 2005;20:807-13.
Havinga P, van der Velden C, de Gee A, van der Poel A. Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands. Harm Reduct J. 2014;11:6.
King J, McManus H, Kwon A, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2022. Sydney: University of New South Wales, Institute TK; 2022.
Power J, Brown G, Lyons A, Thorpe R, Dowsett GW, Lucke J. HIV Futures 8: protocol for a repeated cross-sectional and longitudinal survey of people living with HIV in Australia. Front Public Health. 2017;5:50.
AIHW. Alcohol, tobacco & other drugs in Australia. Canberra, Australia: Autralian Institute of Health and Wellbeing; 2022.
Sutherland R, Uporova J, King C, Jones F, Karlsson A, Gibbs D, et al. Australian drug trends 2022: key findings from the national illicit drug reporting system (IDRS) interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2022.
Brown G, Mikołajczak G, Lyons A, Power J, Drummond F, Cogle A, et al. Development and validation of PozQoL: a scale to assess quality of life of PLHIV. BMC Public Health. 2018;18:527.
Cama E, Broady T, Brener L, Hopwood M, de Wit J, Treloar C. Stigma indicators monitoring project: summary report. Sydney: Centre for Social Research in Health, UNSW Sydney; 2018.
Bui H, Zablotska-Manos I, Hammoud M, Jin F, Lea T, Bourne A, et al. Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study. Int J Drug Policy. 2018;55:222-30.
Prestage G, Grierson J, Bradley J, Hurley M, Hudson J. The role of drugs during group sex among gay men in Australia. Sex Health. 2009;6:310-7.
Broady T, Mao L, Bavinton B, Mckenzie T, Batrouney C, Burnett C, et al. Gay community periodic survey: Melbourne 2019. Sydney: Centre for Social Research in Health, UNSW Sydney; 2019.
Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S, et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex Health. 2023;20:1-8.
Kanazawa JT, Saberi P, Sauceda JA, Dubé K. The LAIs are coming! Implementation science considerations for long-acting injectable antiretroviral therapy in the United States: a scoping review. AIDS Res Hum Retroviruses. 2021;37:75-88.
Schroeder SE, Higgs P, Winter R, Brown G, Pedrana A, Hellard M, et al. Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia. Int J AIDS Soc. 2019;22:e25288.
Heywood W, Lyons A. HIV and elevated mental health problems: diagnostic, treatment, and risk patterns for symptoms of depression, anxiety, and stress in a national community-based cohort of gay men living with HIV. AIDS Behav. 2016;20:1632-45.
Berg RC, Page S, Øgård-Repål A. The effectiveness of peer-support for people living with HIV: a systematic review and meta-analysis. PLoS One. 2021;16:e0252623.
Power J, Lea T, Melendez-Torres GJ, Lyons A, Norman T, Hill AO, et al. Health literacy, financial insecurity and health outcomes among people living with HIV in Australia. Health Promot Int. 2022;37:daac161.
Norman T, Power J, Rule J, Chen J, Bourne A. HIV Futures 10: quality of life among people living with HIV in Australia. Melbourne, Australia: Australian Research Centre in Sex, Health and Society, La Trobe University; 2022.
Kay ES, Creasy S, Batey DS, Coulter R, Egan JE, Fisk S, et al. Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study. BMJ Open. 2022;12:e067219.
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131:23-35.
Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one's HIV-positive status, stigma and social support. AIDS Care. 2008;20:1266-75.